These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 19379152

  • 1. Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress/rest perfusion magnetic resonance imaging.
    Bohl S, Kassner U, Eckardt R, Utz W, Mueller-Nordhorn J, Busjahn A, Thomas HP, Abdel-Aty H, Klingel R, Marcovina S, Dietz R, Steinhagen-Thiessen E, Schulz-Menger J, Vogt A.
    Ther Apher Dial; 2009 Apr; 13(2):129-37. PubMed ID: 19379152
    [Abstract] [Full Text] [Related]

  • 2. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography.
    Jaeger BR, Bengel FM, Odaka K, Uberfuhr P, Labarrere CA, Bengsch S, Engelschalk C, Kreuzer E, Reichart B, Schwaiger M, Seidel D.
    J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844
    [Abstract] [Full Text] [Related]

  • 3. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T, Lennertz A, Schenzle D, Dräger J, Direct adsorption of lipoproteins (DALI) study group.
    J Clin Apher; 2002 Dec; 17(4):161-9. PubMed ID: 12494408
    [Abstract] [Full Text] [Related]

  • 4. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D, Sönmez H, Ekmekçi H, Ulutin T, Oztürk Z, Kökoğlu E, Bayram C, Soner A, Domaniç N.
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [Abstract] [Full Text] [Related]

  • 5. The first case report of the treatment of transplant coronary artery disease with dextran sulfate adsorption lipid apheresis.
    Sosland RP, Gollub SB, Wilson DB, Moriarty PM.
    Ther Apher Dial; 2010 Apr; 14(2):218-21. PubMed ID: 20438545
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
    Wendler T, Schilling R, Lennertz A, Sodemann K, Kleophas W, Messner H, Riechers G, Wagner J, Keller C, Bosch T.
    J Clin Apher; 2003 Apr; 18(4):157-66. PubMed ID: 14699591
    [Abstract] [Full Text] [Related]

  • 7. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.
    Pusl T, Broedl UC, Parhofer KG, Otto C.
    Clin Hemorheol Microcirc; 2009 Apr; 41(2):137-42. PubMed ID: 19252236
    [Abstract] [Full Text] [Related]

  • 8. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H, Shigematsu H, Ishimaru S, Iwai T, Akaba N, Umezu S.
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [Abstract] [Full Text] [Related]

  • 9. [Combined evaluation of myocardial perfusion and contractility by cardiac magnetic resonance with adenosine stress test: feasibility and accuracy in detecting coronary artery disease].
    Dellegrottaglie S, Cospite V, Pedrotti P, Pedretti S, Lanzarin B, Mauri F, Roghi A.
    G Ital Cardiol (Rome); 2009 Feb; 10(2):101-7. PubMed ID: 19348147
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D.
    Z Kardiol; 2003 Feb; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [Abstract] [Full Text] [Related]

  • 13. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
    Ma JY, Qian JY, Jin H, Chen ZW, Chang SF, Yang S, Sun AJ, Zeng MS, Zou YZ, Ge JB.
    Chin Med J (Engl); 2009 Mar 20; 122(6):687-91. PubMed ID: 19323935
    [Abstract] [Full Text] [Related]

  • 14. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre.
    Archontakis S, Pottle A, Hakim N, Ilsley C, Barbir M.
    Int J Clin Pract; 2007 Nov 20; 61(11):1834-42. PubMed ID: 17935547
    [Abstract] [Full Text] [Related]

  • 15. Magnetic resonance myocardial perfusion imaging-First experience at 3.0T.
    Klumpp B, Hoevelborn T, Fenchel M, Stauder NI, Kramer U, May A, Gawaz MP, Claussen CD, Miller S.
    Eur J Radiol; 2009 Jan 20; 69(1):165-72. PubMed ID: 18024045
    [Abstract] [Full Text] [Related]

  • 16. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography.
    Safarova MS, Ezhov MV, Afanasieva OI, Matchin YG, Atanesyan RV, Adamova IY, Utkina EA, Konovalov GA, Pokrovsky SN.
    Atheroscler Suppl; 2013 Jan 20; 14(1):93-9. PubMed ID: 23357149
    [Abstract] [Full Text] [Related]

  • 17. [Screening of asymptomatic coronaropathy with adenosine stress myocardial perfusion MRI: a pilot study].
    Brisbois D, Raskinet B, Djekic J, Morar A, Broussaud T, Mancini I, Magotteaux P, Nchimi A.
    JBR-BTR; 2007 Jan 20; 90(2):92-6. PubMed ID: 17555067
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is lipoprotein (a)-apheresis useful?
    Bambauer R.
    Ther Apher Dial; 2005 Apr 20; 9(2):142-7. PubMed ID: 15828926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.